NASDAQ:CBAY
CymaBay Therapeutics Inc
- Stock
Last Close
32.47
21/03 20:00
Market Cap
2.61B
Beta: 0.26
Volume Today
8.35M
Avg: 1.67M
PE Ratio
−23.78
PFCF: −42.19
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 10M - | 31.07M - | ||||||||||
cost of revenue | 800K - | 632K 21% | 688K 8.86% | 710K 3.20% | 681K 4.08% | |||||||
gross profit | 10M - | -800K - | -632K 21% | -688K 8.86% | -710K 3.20% | 30.39M 4,380.56% | ||||||
selling and marketing expenses | ||||||||||||
general and administrative expenses | 4.87M - | 8.19M 68.04% | 8.87M 8.38% | 9.64M 8.73% | 12.39M 28.43% | 14.38M 16.10% | 19.24M 33.77% | 17.43M 9.42% | 23.04M 32.22% | 25.12M 9.01% | 51.95M 106.85% | |
selling general and administrative expenses | 4.87M - | 8.19M 68.04% | 8.87M 8.38% | 9.64M 8.73% | 12.39M 28.43% | 14.38M 16.10% | 19.24M 33.77% | 17.43M 9.42% | 23.04M 32.22% | 25.12M 9.01% | 51.95M 106.85% | |
research and development expenses | 4.53M - | 15.82M 249.68% | 17.03M 7.60% | 15.94M 6.37% | 18.94M 18.80% | 58.12M 206.92% | 83.84M 44.24% | 35.88M 57.20% | 64.54M 79.87% | 68.00M 5.35% | 80.12M 17.83% | |
other expenses | 135K - | -7.23M 5,454.07% | 11.12M 253.86% | 76K 99.32% | -5.77M 7,696.05% | -3.29M 43.05% | 5.08M 254.35% | 1.76M - | ||||
cost and expenses | 9.40M - | 24.01M 155.51% | 25.90M 7.87% | 25.59M 1.20% | 31.32M 22.43% | 72.50M 131.46% | 103.08M 42.16% | 53.31M 48.28% | 87.58M 64.30% | 93.11M 6.31% | 132.75M 42.57% | |
operating expenses | 9.40M - | 24.01M 155.51% | 25.90M 7.87% | 25.59M 1.20% | 31.32M 22.43% | 72.50M 131.46% | 103.08M 42.16% | 53.31M 48.28% | 87.58M 64.30% | 93.11M 6.31% | 132.07M 41.84% | |
interest expense | 822K - | 755K 8.15% | 913K 20.93% | 1.34M 46.44% | 1.08M 19.22% | 336K 68.89% | 2.58M - | 14.91M 477.12% | 18.95M 27.09% | |||
ebitda | -9.20M - | -31.14M 238.67% | -14.59M 53.14% | -25.30M 73.39% | -26.44M 4.49% | -71.70M 171.16% | -97.73M 36.31% | -53.38M 45.38% | -86.73M 62.47% | -91.09M 5.04% | -101.00M 10.87% | |
operating income | -9.40M - | -24.01M 155.51% | -25.90M 7.87% | -25.59M 1.20% | -21.32M 16.65% | -72.50M 240% | -108.15M 49.16% | -52.60M 51.36% | -87.58M 66.50% | -93.11M 6.31% | -101.68M 9.20% | |
depreciation and amortization | 55K - | 18K 67.27% | 22K 22.22% | 29K 31.82% | 35K 20.69% | 105K 200% | 10.42M 9,820.95% | -778K 107.47% | 855K 209.90% | 2.02M 135.91% | 681K 66.24% | |
total other income expenses net | 135K - | -7.23M 5,454.07% | 11.12M 253.86% | 76K 99.32% | -5.77M 7,696.05% | -3.69M 36.00% | 5.34M 244.57% | 1.62M 69.75% | -2.42M 249.50% | -12.89M 433.53% | -3.69M 71.37% | |
income before tax | -10.07M - | -31.92M 216.86% | -15.53M 51.35% | -26.67M 71.75% | -27.56M 3.32% | -72.55M 163.27% | -102.81M 41.71% | -50.99M 50.41% | -90.00M 76.52% | -106.00M 17.78% | -105.37M 0.60% | |
income tax expense | 957K - | -6.47M 776.38% | 12.03M 285.91% | 1.41M 88.26% | -4.69M 432.13% | 293K 106.24% | -572K 295.22% | -2.32M 305.77% | 2.58M 211.29% | 12.89M 399.03% | ||
net income | -10.07M - | -31.92M 216.86% | -15.53M 51.35% | -26.67M 71.75% | -27.56M 3.32% | -72.55M 163.27% | -102.24M 40.92% | -48.66M 52.40% | -92.58M 90.24% | -118.89M 28.42% | -105.37M 11.37% | |
weighted average shs out | 14.06M - | 12.04M 14.36% | 18.90M 56.93% | 23.40M 23.78% | 34.88M 49.10% | 57.81M 65.72% | 67.03M 15.96% | 68.89M 2.77% | 71.06M 3.14% | 87.80M 23.57% | 106.20M 20.96% | |
weighted average shs out dil | 14.06M - | 12.05M 14.33% | 18.92M 57.00% | 23.45M 23.95% | 34.90M 48.86% | 57.84M 65.71% | 67.03M 15.90% | 68.89M 2.77% | 71.06M 3.14% | 87.80M 23.57% | 106.20M 20.96% | |
eps | -0.72 - | -2.65 268.06% | -0.82 69.06% | -1.14 39.02% | -0.79 30.70% | -1.25 58.23% | -1.53 22.40% | -0.71 53.59% | -1.30 83.10% | -1.35 3.85% | -0.99 26.67% | |
epsdiluted | -0.72 - | -2.65 268.06% | -0.82 69.06% | -1.14 39.02% | -0.79 30.70% | -1.25 58.23% | -1.53 22.40% | -0.71 53.59% | -1.30 83.10% | -1.35 3.85% | -0.99 26.67% |
All numbers in USD (except ratios and percentages)